EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Value of Pre‐Treatment Diffusion Kurtosis Imaging for Progression‐Free Survival Prediction in Advanced Nasopharyngeal Carcinoma

Wang Ren iD, Xiang Zheng, Shizhong Wu, Caixia Wu, Dechun Zheng iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.70883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Wang Ren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Diffusion Magnetic Resonance Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Natural Science Foundation, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to evaluate the value of diffusion kurtosis imaging (DKI) for prognostic value for long‐term PFS in nasopharyngeal carcinoma (NPC).

Methods

A cohort of 295 NPC patients underwent pretreatment 3.0T MRI with DKI to derive mean kurtosis (MK), mean diffusion (MD), and apparent diffusion coefficient (ADC). Clinical parameters (Tumor stage, EBV‐DNA, neoadjuvant chemotherapy regimens) were recorded. Follow‐up extended to December 2023. Statistical analyses (R software v4.3.0) included univariate/multivariate Cox regression and Kaplan–Meier survival analysis. A prognostic nomogram integrating key predictors was developed.

Results

Median 10‐year follow‐up revealed 2‐, 5‐, and 10‐year PFS rates of 89%, 79%, and 74%, respectively. Univariate Cox regression analysis demonstrated that T stage, Clinical Stages, NAC regimens, ADC_Group, MK_Group, and MD_Group were significant prognostic factors for PFS in NPC ( p < 0.05). Multivariate analysis identified Clinical Stage (HR = 2.230, 95% CI 1.44–3.66, p < 0.001), NAC (neoadjuvant chemotherapy) regimens (HR = 0.56, 95% CI 0.35–0.90, p = 0.017), and MK_Group (HR = 0.52, 95% CI 0.33–0.82, p = 0.003) as independent prognostic factors. The MK_Group high exhibited superior survival rates versus MK_Group low (2‐year: 94% vs. 81%; 5‐year: 85% vs. 66%; 10‐year: 79% vs. 64%; all p < 0.05). The nomogram combining Clinical Stage, NAC, and MK_Group demonstrated moderate predictive accuracy for 2‐, 5‐, and 10‐year PFS (AUC = 0.736, 0.718, 0.697).

Conclusion

Pretreatment MK serves as a robust noninvasive biomarker for long‐term PFS in NPC. Integration with Clinical Stage and NAC regimens enhances prognostic stratification, supporting personalized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsDiffusion Magnetic Resonance ImagingHumansMaleFemaleMiddle AgedPrognosisAdultAgedProgression-Free SurvivalNomogramsNeoplasm StagingRetrospective StudiesNeoadjuvant TherapyYoung Adult

Stichwörter der Autor:innen

diffusion kurtosis imagingmagnetic resonance imagingnasopharyngeal carcinomaprogression‐free survival

Autor:innen und Institutionen

  • Department of Radiology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.

ORCID-Profile: Wang Ren, Dechun Zheng

Förderung

  • Fujian Provincial Natural Science Foundation
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Ren, W., Zheng, X., Wu, S., Wu, C., & Zheng, D. (2025). Prognostic Value of Pre‐Treatment Diffusion Kurtosis Imaging for Progression‐Free Survival Prediction in Advanced Nasopharyngeal Carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.70883

Vancouver

Ren W, Zheng X, Wu S, Wu C, Zheng D. Prognostic Value of Pre‐Treatment Diffusion Kurtosis Imaging for Progression‐Free Survival Prediction in Advanced Nasopharyngeal Carcinoma. Cancer Medicine. 2025. doi:10.1002/cam4.70883

BibTeX
@article{Ren2025,
  author = {Ren, Wang and Zheng, Xiang and Wu, Shizhong and Wu, Caixia and Zheng, Dechun},
  title = {Prognostic Value of Pre‐Treatment Diffusion Kurtosis Imaging for Progression‐Free Survival Prediction in Advanced Nasopharyngeal Carcinoma},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70883}
}
Kostenlos starten →